Low-dose gemcitabine plus nab-paclitaxel versus standard-dose gemcitabine plus nab-paclitaxel in elderly patients with metastatic pancreatic cancer: A randomized Phase II trial.
JGH open : an open access journal of gastroenterology and hepatology（2023）
摘要
Low-dose GnP had an equivalent efficacy to conventional therapy; however, it did not reduce adverse events.
更多查看译文
关键词
chemotherapy,elderly,gemcitabine,nab‐paclitaxel,pancreatic cancer
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要